Literature DB >> 3284961

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera.

M G Roncarolo1, H Yssel, J L Touraine, H Betuel, J E De Vries, H Spits.   

Abstract

T cell clones of donor origin that specifically react with recipient cells were obtained from a SCID patient successfully reconstituted by allogeneic fetal liver and thymus transplantation performed 10 yr ago. The majority of these clones displayed both cytotoxic and proliferative responses towards PBL and an EBV-transformed B cell line derived from the patient. In addition, these T cell clones had proliferative and cytotoxic responses towards the parental PBL, EBV cell lines, and PHA blasts. Blocking studies with anti-class I and anti-class II HLA mAbs indicated that the activity of the CD4+ T cell clones was specifically directed against class II HLA antigens of the recipient. On the other hand, the cytotoxic and proliferative responses of the CD8+ T cell clones were specific for class I HLA antigens which are ubiquitously expressed on the recipient cells. Thus, the establishment of transplantation tolerance observed in this stable human chimera is not due to the elimination of host-reactive T cells from the repertoire and suggests the presence of a peripheral autoregulatory suppressor mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284961      PMCID: PMC2188931          DOI: 10.1084/jem.167.5.1523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Autocytotoxic and autosuppressor T-cell lines generated from autologous lymphocyte cultures.

Authors:  K Rosenkrantz; B Dupont; D Williams; N Flomenberg
Journal:  Hum Immunol       Date:  1987-07       Impact factor: 2.850

2.  Transplantation of hematopoietic cells for lethal congenital immunodeficiencies.

Authors:  R J O'Reilly; N Kapoor; D Kirkpatrick; N Flomenberg; M S Pollack; B Dupont; R A Good; Y Reisner
Journal:  Birth Defects Orig Artic Ser       Date:  1983

3.  Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent.

Authors:  V Quaranta; L E Walker; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.

Authors:  H Yssel; J E De Vries; M Koken; W Van Blitterswijk; H Spits
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

Review 5.  Bone-marrow and fetal-liver transplantation in immunodeficiencies and inborn errors of metabolism: lack of significant restriction of T-cell function in long-term chimeras despite HLA-mismatch.

Authors:  J L Touraine
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  A possible new HLA-DR allele.

Authors:  H Betuel; L Gebuhrer; J Lambert; A C Freidel; A Farre
Journal:  Hum Immunol       Date:  1983-11       Impact factor: 2.850

7.  Immunodeficiency diseases and expression of HLA antigens.

Authors:  J L Touraine; H Bétuel
Journal:  Hum Immunol       Date:  1981-03       Impact factor: 2.850

8.  Suppressor cells in transplantation tolerance. III. The role of antigen in the maintenance of transplantation tolerance.

Authors:  P J Tutschka; A D Hess; W E Beschorner; G W Santos
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

9.  Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones.

Authors:  A Bensussan; S C Meuer; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  22 in total

1.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

2.  Key role of macrophages in tolerance induction via T regulatory type 1 (Tr1) cells.

Authors:  B Mfarrej; T Jofra; C Morsiani; N Gagliani; G Fousteri; M Battaglia
Journal:  Clin Exp Immunol       Date:  2020-05-13       Impact factor: 4.330

3.  Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

Authors:  J Punnonen; G Aversa; B G Cocks; A N McKenzie; S Menon; G Zurawski; R de Waal Malefyt; J E de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

4.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

Authors:  R Bacchetta; B A Vandekerckhove; J L Touraine; M Bigler; S Martino; L Gebuhrer; J E de Vries; H Spits; M G Roncarolo
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Immunological lessons learnt from patients transplanted with fully mismatched stem cells.

Authors:  Jean-Louis Touraine; Hélène Plotnicky; Maria-Grazia Roncarolo; Rosa Bacchetta; Lucette Gebuhrer
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Transplantation tolerance induced in humans at the fetal or the neonatal stage.

Authors:  Jean-Louis Touraine; Kamel Sanhadji
Journal:  J Transplant       Date:  2011-08-18

Review 8.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330

Review 9.  Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.

Authors:  Patricia Solé; Pere Santamaria
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

10.  The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.

Authors:  Silvia Gregori; Kevin S Goudy; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2012-02-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.